Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Monica Munera-Campos"'
Autor:
José-Juan Pereyra-Rodríguez, Pedro Herranz, Ricardo Ruiz-Villaverde, Marta Elosua-González, Manuel Galán-Gutiérrez, Ignasi Figueras-Nart, Javier Miquel, Pablo de la Cueva, Esther Serra-Baldrich, Monica Munera-Campos, Gemma Melé-Ninot, Vicente Expósito-Serrano, Bibiana Perez, Amalia Serrano, Javier F Ortiz de Frutos, José C Armario-Hita
Publikováno v:
Clinical and Experimental Dermatology.
Background Tralokinumab was recently approved for the treatment of moderate-to-severe atopic dermatitis (AD) and is the first selective interleukin (IL)-13 inhibitor that specifically neutralizes IL-13 with high affinity. Objectives To determine the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a588f39220d31984807e6ed0b3da363
https://doi.org/10.1093/ced/llad153
https://doi.org/10.1093/ced/llad153
Publikováno v:
Indian Journal of Dermatology, Vol 65, Iss 3, Pp 214-216 (2020)
The widespread use of anti-programmed cell death receptor-1 (PD-1) agents has shed light to unusual immune-related adverse effects, especially affecting the skin. We report a case of bullous pemphigoid secondary to nivolumab therapy for metastatic re
Externí odkaz:
https://doaj.org/article/6b4e972e3a3b4e25b8ef996336497d8a